Sirpa L.
- Country
- Finland
- Department
- Comprehensive cancer center
Research Overview
- A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured GLPG5101 (19CP02) in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma
- Evaluation of Epcoritamab in Combination with Chemotherapeutic Agents in B-cell Non-Hodgkin Lymphoma: A Phase 1b/2 Open-Label Study
- Efficacy and Safety of Golcadomide with R-CHOP Versus Placebo with R-CHOP in High-risk Large B-cell Lymphoma: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 167 of 354 partner sites.
Specializations
Lymphoma Research Focus
This investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on non-Hodgkin lymphoma and its subtypes. Their expertise extends to both newly diagnosed and relapsed/refractory cases.
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
The investigator's work encompasses both aggressive and indolent lymphoma variants.
Treatment Innovations
The investigator focuses on developing novel therapeutic approaches including gene-modified T-cell therapies and innovative drug combinations. Their research includes evaluation of new agents such as epcoritamab and glofitamab.
- Targeted Immunotherapies
- Combination Treatment Strategies
- Cell-Based Therapies
Their work includes assessment of both standard and experimental therapeutic approaches.
Clinical Development
The investigator conducts research across multiple treatment phases, from early-stage dose-escalation studies to advanced comparative efficacy trials. Their work includes evaluation of long-term safety profiles and treatment outcomes.
- Safety and Efficacy Assessments
- Treatment Response Evaluation
- Long-term Patient Monitoring
The research encompasses both adult and pediatric patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.